Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction

Apomorphine is now recognised as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed for patients with advanced Parkinson's disease (PD) with motor fluctuations in Europe, Asia and more recently on the other three continents. In light of its most recent uses and newest challenges, this paper focuses on a number of indications in Parkinson's disease and beyond, which are currently under development or which would benefit from development, given the generally high levels of evidence: sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury and sexual dysfunction.

Authors

Institutions

Publication Details

Journal
Parkinsonism & Related Disorders
Published
2025-04-18
DOI
https://doi.org/10.1016/j.parkreldis.2025.107837
Citations
2
Primary Topic
Restless Legs Syndrome Research
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction

Marc Vérin, Manon Auffret
2 citations
Parkinsonism & Related Disorders
Restless Legs Syndrome Research
2.71
article

Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction

Marc Vérin, Manon Auffret
article en
2 citations

Abstract

Apomorphine is now recognised as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed for patients with advanced Parkinson's disease (PD) with motor fluctuations in Europe, Asia and more recently on the other three continents. In light of its most recent uses and newest challenges, this paper focuses on a number of indications in Parkinson's disease and beyond, which are currently under development or which would benefit from development, given the generally high levels of evidence: sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury and sexual dysfunction.

Parkinsonism & Related DisordersVol. 139
Université d'Orléans (FR)
Good health and well-being
Openalex Percentile: Top 11%
Restless Legs Syndrome Research
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction — Marc Vérin, Manon Auffret · Parkinsonism & Related Disorders (2025) | TGRS Research Map | TGRS